Endocrinology, Vol 108, 2293-2301, Copyright © 1981 by Endocrine Society

ARTICLES

1,25-dihydroxycholecalciferol stimulates osteoclasts in rat bones in the absence of parathyroid hormone

ME Holtrop, KA Cox, MB Clark, MF Holick and CS Anast

Three experiments were carried out to test the time course of effects of 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] on the ultrastructural morphometry of osteoclasts. The addition of lactose to a vitamin D- deficient diet with a high calcium and phosphate content, fed to weanling rats for 4 weeks, ensured normacalcemia and normophosphatemia and allowed thyroparathyroidectomy without ill effects. In these vitamin D-deficient thyroparathyroidectomized rats, iv injection of 50 ng 1,25-(OH)2D3 resulted in significant changes in the osteoclasts in the metaphysis of the tibiae compared to those in corresponding controls; the size of these cells, their nuclei, ruffled borders, and clear zones enlarged after 6 h and the number of osteoclasts increased after 48 h. Serum calcium and serum phosphate levels increased after 12 h in one experiment, but not in a second experiment. Serum 25- hydroxyvitamin D and serum immunoreactive parathyroid hormone levels were undetectable. Mineralization of metaphyseal bone matrix was normal, as quantified by histomorphometry. When, dependent on the mineral content in the diet, mineralization was impaired and the volume density of the osteoid seams was increased, activation of osteoclasts by 1,25(OH)2D3 was not seen until 12--24 h after injection. It is concluded that a physiological dose of 1,25-(OH)2D3 stimulates the activity of osteoclasts in the absence of parathyroid hormone.

This article has been cited by other articles:

				G A Clines and T A Guise Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone Endocr. Relat. Cancer, September 1, 2005; 12(3): 549 - 583. [Abstract] [Full Text] [PDF]

				A. Falcao Pedrosa Costa, L. Machado dos Reis, M. Custodio Ribeiro, R. Maria Affonso Moyses, and V. Jorgetti Effects of calcitriol on parathyroid function and on bone remodelling in secondary hyperparathyroidism Nephrol. Dial. Transplant., April 1, 2003; 18(4): 743 - 749. [Abstract] [Full Text] [PDF]

				G. R. Mundy and T. A. Guise Hormonal Control of Calcium Homeostasis Clin. Chem., August 1, 1999; 45(8): 1347 - 1352. [Abstract] [Full Text] [PDF]

				H. Yoshitake, S. R. Rittling, D. T. Denhardt, and M. Noda Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption PNAS, July 6, 1999; 96(14): 8156 - 8160. [Abstract] [Full Text] [PDF]

				Y. C. Li, M. Amling, A. E. Pirro, M. Priemel, J. Meuse, R. Baron, G. Delling, and M. B. Demay Normalization of Mineral Ion Homeostasis by Dietary Means Prevents Hyperparathyroidism, Rickets, and Osteomalacia, But Not Alopecia in Vitamin D Receptor-Ablated Mice Endocrinology, October 1, 1998; 139(10): 4391 - 4396. [Abstract] [Full Text] [PDF]

				T. A. Guise and G. R. Mundy Cancer and Bone Endocr. Rev., February 1, 1998; 19(1): 18 - 54. [Abstract] [Full Text]

				R. G. Erben, A. M. Scutt, D. Miao, U. Kollenkirchen, and M. Haberey Short-Term Treatment of Rats with High Dose 1,25-Dihydroxyvitamin D3 Stimulates Bone Formation and Increases the Number of Osteoblast Precursor Cells in Bone Marrow Endocrinology, November 1, 1997; 138(11): 4629 - 4635. [Abstract] [Full Text] [PDF]